The JOURNAL OF REPRODUCTIVE IMMUNOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal platform for exploring the intricate interactions between reproductive health and the immune system. With an ISSN of 0165-0378 and an E-ISSN of 1872-7603, this esteemed journal spans over four decades, from 1979 to 2024, contributing significantly to the fields of Immunology, Reproductive Medicine, and Obstetrics and Gynecology. Currently ranked in Q2 for Immunology and Allergy and Q1 for both Obstetrics and Gynecology and Reproductive Medicine, it serves as an invaluable resource for researchers, professionals, and students dedicated to advancing knowledge in reproductive health. The journal’s notable impact factor and rigorous peer-review process underscore its commitment to high-quality research, making it an essential reference point for ongoing studies in this ever-evolving discipline. By promoting interdisciplinary discussions and pioneering research findings, the JOURNAL OF REPRODUCTIVE IMMUNOLOGY fosters a deeper understanding of the immune mechanisms that influence reproductive outcomes.

Seminars in Immunopathology is a premier academic journal published by SPRINGER HEIDELBERG, focusing on the intricate relationships between immune responses and pathologies. With an ISSN of 1863-2297 and an E-ISSN of 1863-2300, this journal delivers cutting-edge research and insights to its readers, contributing significantly to the fields of immunology and allergy, as reflected in its Q1 quartile ranking in both categories for 2023. Positioned in a highly competitive niche, it ranks #18 out of 233 in Immunology and Allergy and #22 out of 236 in Immunology and Microbiology, highlighting its impact within the scientific community. Seminars in Immunopathology publishes comprehensive reviews and research articles, aiming to advance understanding of immune mechanisms in disease and promote interdisciplinary collaboration. Accessible from Germany, this journal is a vital resource for researchers, clinicians, and students seeking to stay at the forefront of immunological advancements and therapeutic innovations.

CELLULAR IMMUNOLOGY is a prestigious journal published by Academic Press Inc. Elsevier Science, dedicated to advancing the field of immunology. Established in 1970 and converging ongoing research up to 2024, this journal has carved out a significant niche within the academic community, boasting a notable Q2 ranking in the Immunology category and holding a respectable 67th percentile ranking within Scopus for its contributions to the disciplines of Immunology and Microbiology. The journal serves as a vital platform for disseminating high-quality research, reviews, and methodologies that elucidate the intricacies of cellular immune responses, thereby benefiting researchers, professionals, and students alike. Although it does not offer open access, the journal's impact is evidenced by its comprehensive coverage of pioneering studies and ongoing developments in the immunological sciences, positioning it as an essential resource for those seeking to deepen their understanding and engage with the latest findings in cellular immunology.

Viral Immunology, published by Mary Ann Liebert, Inc, stands as a prominent journal dedicated to advancing the understanding of the interplay between viral infections and host immune responses. With a strong focus on immunology, molecular medicine, and virology, the journal provides a platform for the dissemination of high-quality research findings and innovative methodologies that could shape the future of these critical fields. Although it currently holds a Q3 rating across its relevant categories and a respectable ranking within the Scopus database, Viral Immunology continues to strive for excellence with a commitment to publishing influential research that informs both academic and clinical practices. The journal accepts submissions in various formats—original research, reviews, and commentaries—catering to a diverse readership that includes researchers, professionals, and students engaged in the biological and medical sciences. Readers can anticipate insightful articles that address urgent challenges in immunological responses to viral infections, paving the way for new therapeutic strategies and public health initiatives.

MOLECULAR IMMUNOLOGY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, is a highly regarded journal in the fields of Immunology and Molecular Biology. With a focus on advancing the understanding of the immune system at the molecular level, the journal has been a critical resource since its inception in 1975. The journal is currently listed in the second quartile (Q2) of its category as per the 2023 rankings, indicating its substantial impact in both Immunology and Molecular Biology research. Researchers and professionals benefit from the journal's rigorous peer-review process and its commitment to publishing high-quality original research, reviews, and methodological studies that explore the intricate dynamics of immune responses. Although it does not currently offer an open access option, MOLECULAR IMMUNOLOGY remains an essential platform for scholars, emphasizing the significance of molecular interactions within the immune system and their implications in health and disease.

INTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.

Scandinavian Journal of Immunology is a prestigious peer-reviewed journal published by Wiley, focused on the evolving field of immunology and its interdisciplinary ties with medicine. Since its inception in 1972, this journal has cultivated a rich repository of knowledge, showcasing innovative research and reviews that contribute to the understanding of immune system functions, disorders, and therapeutic interventions. With an impressive impact factor reflecting a Q2 ranking in Immunology and a top-tier Q1 status in miscellaneous Medicine categories for 2023, it is recognized for its high-quality scholarly output, positioning it among the leading journals in the field. Additionally, its Scopus ranking of #84 out of 236 in Immunology underscores its significance and relevance to both emerging and established researchers. Although it does not currently offer open access options, the journal’s expansive reach and rigorous publication standards make it an essential platform for disseminating impactful research to the global scientific community. The journal invites submissions that explore the complexities of the immune system, aiming to bridge clinical and basic science for a comprehensive understanding of immunological phenomena.

CLINICAL IMMUNOLOGY is a premier academic journal dedicated to the field of immunology, published by Academic Press Inc. Elsevier Science. With a robust impact reflected in its recent categorization as Q2 in Immunology and Q1 in Immunology and Allergy for 2023, this journal stands out as a key resource for researchers and professionals alike. Featuring a diverse array of articles from fundamental laboratory studies to advanced clinical applications, CLINICAL IMMUNOLOGY aims to disseminate significant research findings that contribute to the evolving landscape of immunological science. Its notable Scopus rankings underscore its esteemed position, with ranks of #33 and #36 in the respective categories, highlighting its commitment to high-quality scholarly work. Although not an open-access journal, it ensures access to valuable insights and developments in the immune response and related fields, making it an indispensable tool for students and professionals aiming to stay at the forefront of immunological research.

Veterinary Immunology and Immunopathology is a premier journal published by Elsevier, dedicated to advancing the field of veterinary science through rigorous investigations into the immunological mechanisms that underpin disease resistance, pathogenesis, and therapeutic interventions in animals. With an established history since 1979, this journal has consistently provided a platform for high-quality research, bridging the gap between immunology and veterinary medicine. The current impact factor reflects its significance within the field, particularly noted for its Q3 ranking in Immunology and Q2 in miscellaneous Veterinary categories as of 2023. The journal caters to a diverse audience, from seasoned researchers to students, by publishing original research, reviews, and case studies that explore pivotal topics such as vaccine development, immune response in various species, and the role of genetics in immunological disorders. Notably, it is indexed in Scopus, where it ranks in the top percentile of veterinary science disciplines, enhancing its visibility and impact within the scientific community. For those seeking to stay at the forefront of veterinary immunology, this journal is an invaluable resource.

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.